These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23651532)

  • 1. Standard or hypofractionated radiotherapy in the postoperative treatment of breast cancer: a retrospective analysis of acute skin toxicity and dose inhomogeneities.
    Tortorelli G; Di Murro L; Barbarino R; Cicchetti S; di Cristino D; Falco MD; Fedele D; Ingrosso G; Janniello D; Morelli P; Murgia A; Ponti E; Terenzi S; Tolu B; Santoni R
    BMC Cancer; 2013 May; 13():230. PubMed ID: 23651532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective study of adjuvant proton radiotherapy for breast cancer after lumpectomy: a comparison of conventional-dose and hypofractionated dose.
    Hong Z; Yang Z; Mei X; Li P; Bao C; Wang Z; Cai X; Ming X; Wang W; Guo X; Yu X; Zhang Q
    Radiat Oncol; 2023 Mar; 18(1):56. PubMed ID: 36959653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors of influence on acute skin toxicity of breast cancer patients treated with standard three-dimensional conformal radiotherapy (3D-CRT) after breast conserving surgery (BCS).
    Kraus-Tiefenbacher U; Sfintizky A; Welzel G; Simeonova A; Sperk E; Siebenlist K; Mai S; Wenz F
    Radiat Oncol; 2012 Dec; 7():217. PubMed ID: 23249653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing acute and late toxicity in the era of adjuvant hypofractionated breast radiotherapy.
    De Santis MC; Bonfantini F; Di Salvo F; Dispinzieri M; Mantero E; Soncini F; Baili P; Sant M; Bianchi G; Maggi C; Di Cosimo S; Agresti R; Pignoli E; Valdagni R; Lozza L
    Breast; 2016 Oct; 29():90-5. PubMed ID: 27476083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute radiodermatitis in modern adjuvant 3D conformal radiotherapy for breast cancer - the impact of dose distribution and patient related factors.
    Borm KJ; Loos M; Oechsner M; Mayinger MC; Paepke D; Kiechle MB; Combs SE; Duma MN
    Radiat Oncol; 2018 Nov; 13(1):218. PubMed ID: 30404664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Outcomes Using Hypofractionated Tumor Bed Boost Combined With Hypofractionated Whole Breast Irradiation for Early-stage Breast Cancer.
    Yu E; Huang D; Leonard K; Dipetrillo T; Wazer D; Hepel J
    Clin Breast Cancer; 2017 Dec; 17(8):638-643. PubMed ID: 28629952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypofractionated radiotherapy after conservative surgery for breast cancer: analysis of acute and late toxicity.
    Deantonio L; Gambaro G; Beldì D; Masini L; Tunesi S; Magnani C; Krengli M
    Radiat Oncol; 2010 Nov; 5():112. PubMed ID: 21092288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated hypofractionated whole-breast irradiation with concomitant daily boost in early breast cancer.
    Kyrgias G; Zygogianni A; Theodorou K; Koukourakis M; Oikonomou A; Kouvaris J; Kouloulias V
    Am J Clin Oncol; 2015 Aug; 38(4):358-63. PubMed ID: 23934132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: results of a prospective trial.
    Krug D; Baumann R; Krockenberger K; Vonthein R; Schreiber A; Boicev A; Würschmidt F; Weinstrauch E; Eilf K; Andreas P; Höller U; Dinges S; Piefel K; Zimmer J; Dellas K; Dunst J
    Strahlenther Onkol; 2021 Jan; 197(1):48-55. PubMed ID: 33001241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypofractionated Whole Breast Irradiation and Simultaneous Integrated Boost in Large-breasted Patients: Long-term Toxicity and Cosmesis.
    De Rose F; Fogliata A; Franceschini D; Iftode C; D'Agostino GR; Comito T; Franzese C; Di Brina L; Clerici E; Loi M; Navarria P; Gatzemeier W; Testori A; Tinterri C; Lobefalo F; Tomatis S; Cozzi L; Scorsetti M
    Clin Breast Cancer; 2020 Dec; 20(6):527-533. PubMed ID: 32665192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute radiation dermatitis and pneumonitis in Japanese breast cancer patients with whole breast hypofractionated radiotherapy compared to conventional radiotherapy.
    Osako T; Oguchi M; Kumada M; Nemoto K; Iwase T; Yamashita T
    Jpn J Clin Oncol; 2008 May; 38(5):334-8. PubMed ID: 18417501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypofractionated Whole-Breast Irradiation in Large-Breasted Women-Is There a Dosimetric Predictor for Acute Skin Toxicities?
    Patel AK; Ling DC; Richman AH; Champ CE; Huq MS; Heron DE; Beriwal S
    Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):71-77. PubMed ID: 30145393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensity-modulated and hypofractionated simultaneous integrated boost adjuvant breast radiation employing statics ports of tomotherapy (TomoDirect): a prospective phase II trial.
    Franco P; Zeverino M; Migliaccio F; Cante D; Sciacero P; Casanova Borca V; Torielli P; Arrichiello C; Girelli G; La Porta MR; Tofani S; Numico G; Ricardi U
    J Cancer Res Clin Oncol; 2014 Jan; 140(1):167-77. PubMed ID: 24292425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of intermediate time between chemotherapy and hypofractionated radiotherapy to the radiation induced skin toxicity for breast adjuvant treatment.
    Zygogianni A; Kouloulias V; Antypas C; Armpilia C; Kyrgias G; Kouvaris J
    Breast J; 2014; 20(1):74-8. PubMed ID: 24237451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin toxicity from external beam radiation therapy in breast cancer patients: protective effects of Resveratrol, Lycopene, Vitamin C and anthocianin (Ixor®).
    Di Franco R; Calvanese M; Murino P; Manzo R; Guida C; Di Gennaro D; Anania C; Ravo V
    Radiat Oncol; 2012 Jan; 7():12. PubMed ID: 22289566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensity modulated radiotherapy with simultaneous integrated boost vs. conventional radiotherapy with sequential boost for breast cancer - A preliminary result.
    Lee HH; Hou MF; Chuang HY; Huang MY; Tsuei LP; Chen FM; Ou-Yang F; Huang CJ
    Breast; 2015 Oct; 24(5):656-60. PubMed ID: 26371691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preliminary results of whole breast helical tomotherapy with simultaneous integrated boost in the adjuvant treatment of breast cancer].
    Liem X; Chira C; Fourquet A; Campana F; Peurien D; Fournier-Bidoz N; Kirova YM
    Cancer Radiother; 2014 Jan; 18(1):15-22. PubMed ID: 24316350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-surface analysis for prediction of severe acute radio-induced skin toxicity in breast cancer patients.
    Pastore F; Conson M; D'Avino V; Palma G; Liuzzi R; Solla R; Farella A; Salvatore M; Cella L; Pacelli R
    Acta Oncol; 2016; 55(4):466-73. PubMed ID: 26623532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation-induced DNA damage and repair in lymphocytes from breast cancer patients and their correlation with acute skin reactions to radiotherapy.
    Popanda O; Ebbeler R; Twardella D; Helmbold I; Gotzes F; Schmezer P; Thielmann HW; von Fournier D; Haase W; Sautter-Bihl ML; Wenz F; Bartsch H; Chang-Claude J
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1216-25. PubMed ID: 12654430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute toxicity of normofractionated intensity modulated radiotherapy with simultaneous integrated boost compared to three-dimensional conformal radiotherapy with sequential boost in the adjuvant treatment of breast cancer.
    Krug D; Köder C; Häfner MF; Arians N; Harrabi SB; Koerber SA; Forster T; Schlampp I; Sohn C; Heil J; Hof H; Hörner-Rieber J; Debus J
    Radiat Oncol; 2020 Oct; 15(1):235. PubMed ID: 33050920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.